Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$124.1M
+33.3% from 2023
Prescriptions
6,477
$19,160.94 per claim
Patients
1,169
1,215 prescribers
Total spending, 2024
$124.1M
$106,163.74 per patient
Medicare prescription drug plans paid $124.1M for Tabrecta in 2024, for 6,477 prescriptions and refills to 1,169 patients (up 33.3% from 2023). The average cost per claim was $19,160.94.
California had the highest Medicare cost for Tabrecta in 2024: $21.0M for 1,083 claims, followed by New York ($9.5M).
Anh Pham, hematology-oncology in Duarte, CA, had the highest Medicare cost for Tabrecta in 2024: 37 claims costing $831K.
Tabrecta is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Anh Pham Duarte, CA | Hematology-Oncology | 37 | Under 11 | $831K |
| Nicolas A Villanueva Honolulu, HI | Hematology-Oncology | 29 | Under 11 | $659K |
| Andrew M Schreiber |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 847 | 3,919 | 779 | $70.2M |
| 2023 | 995 | 4,864 | 978 | $93.1M |
| 2024 | 1,215 | 6,477 | 1,169 | $124.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 36 |
| Under 11 |
| $643K |
| Richard L O'Neal Greenville, SC | Hematology | 28 | Under 11 | $613K |
| Caitlin C Meservey Ann Arbor, MI | Physician Assistant | 33 | Under 11 | $576K |
| Fawzi Abu Rous Lansing, MI | Hematology-Oncology | 26 | Under 11 | $528K |
| Helen Kang Panorama City, CA | Medical Oncology | 25 | Under 11 | $505K |
| David Y Lou Irvine, CA | Internal Medicine | 28 | Under 11 | $493K |
| Marina Chiara Garassino Chicago, IL | Hematology-Oncology | 20 | Under 11 | $464K |
| Sandeep H Mashru Portland, OR | Hematology-Oncology | 23 | Under 11 | $462K |
| Jiahui Chen Roseville, CA | Pharmacist | 27 | Under 11 | $448K |
| Andrew J Piper-Vallillo Boston, MA | Hematology-Oncology | 29 | Under 11 | $445K |
| James Hall San Angelo, TX | Hematology-Oncology | 19 | Under 11 | $435K |
| Ryan A Williams Houston, TX | Hematology-Oncology | 24 | Under 11 | $420K |
| Meide Lu West Reading, PA | Hematology-Oncology | 19 | Under 11 | $420K |
| Jason Kao Stanford, CA | Physician Assistant | 19 | Under 11 | $407K |
| Malti Sharma San Francisco, CA | Nurse Practitioner | 22 | Under 11 | $388K |
| Anthony W Stephens Newburgh, IN | Hematology-Oncology | 16 | Under 11 | $372K |
| Federico Albrecht Miami, FL | Hematology-Oncology | 14 | Under 11 | $364K |
| Jeffrey H Margolis Madison Heights, MI | Hematology-Oncology | 16 | Under 11 | $361K |
| Rachel Rosenblum Middletown, NJ | Medical Oncology | 19 | Under 11 | $360K |
| Eric M Imoto San Jose, CA | Hematology-Oncology | 16 | Under 11 | $347K |
| Jason N Macklis Park Ridge, IL | Hematology-Oncology | 13 | Under 11 | $346K |
| Thomas B Sneed Little Rock, AR | Hematology-Oncology | 15 | Under 11 | $345K |
| Amer G Rassam Tallahassee, FL | Hematology-Oncology | 13 | Under 11 | $342K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 6,477 | $124.1M |